Generic Drug Administration Annual Report 2022 – Health Economist





FDA The Generic Drug Administration has released its 2022 annual report.. Generic drugs play a vital role in saving patients and payers money. For example, pregabalin capsules cost $450 for a 30-day supply at the end of the market exclusivity period, but the price dropped to $23 (a 95% reduction) within the first 12 months after the generic was introduced. The healthcare system saved $6.6 billion on this drug alone. saw a 95% price reduction during the first 12 months of generic sales.

In 2022, the Generic Drug Administration approved 106 first generic drugs. Below are some highlights from the report.

https://www.fda.gov/media/165435/download#page=8
https://www.fda.gov/media/165435/download#page=8